Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Harte-Hanks's Debt-to-EBITDA or its related term are showing as below:
HHS'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -8.82 Med: 1.41 Max: 47.79
Current: 47.79
During the past 13 years, the highest Debt-to-EBITDA Ratio of Harte-Hanks was 47.79. The lowest was -8.82. And the median was 1.41.
HHS's Debt-to-EBITDA is ranked worse than 98.46% of 455
companies
in the Conglomerates industry
Industry Median: 2.71
vs HHS: 47.79
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Harte-Hanks Debt-to-EBITDA Related Terms
Harte-Hanks Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Harte-Hanks's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HHS vs PLAG, LGPS, PTEEF: Debt-to-EBITDA Comparison
For the Conglomerates subindustry, Harte-Hanks's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Harte-Hanks Debt-to-EBITDA vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Harte-Hanks's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Harte-Hanks's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Harte-Hanks (HHS) has a Debt-to-EBITDA of -1.89 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Harte-Hanks. According to the industry distribution chart, Harte-Hanks ranks #448 out of 455 companies in the Conglomerates industry, placing it in the top 98.5%.
Is Harte-Hanks' Debt-to-EBITDA too high?
Harte-Hanks' current Debt-to-EBITDA is -1.89. Based on the distribution chart, Harte-Hanks ranks #448 out of 455 companies in the Conglomerates industry, which is in the bottom quartile relative to peers. Overall, Harte-Hanks has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Harte-Hanks' Debt-to-EBITDA compare to PLAG and LGPS?
According to the Conglomerates industry distribution chart, Harte-Hanks ranks #448 out of 455 companies for Debt-to-EBITDA. This places Harte-Hanks in the lower half of its industry. The industry median Debt-to-EBITDA is 2.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Conglomerates company?
The median Debt-to-EBITDA among Conglomerates companies is 2.71, based on 455 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Harte-Hanks. For the Conglomerates industry, the median Debt-to-EBITDA is 2.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Harte-Hanks's current Debt-to-EBITDA is -1.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harte-Hanks stock overvalued right now?
Based on GuruFocus' analysis, Harte-Hanks (HHS) is currently considered Fairly Valued. The stock's GF Value™ is $4.15, compared to a current price of $4.29 — trading 3.3% above its estimated fair value. The current Debt-to-EBITDA is -1.89. Harte-Hanks' overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Harte-Hanks (HHS), the current Debt-to-EBITDA is -1.89 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Harte-Hanks (HHS) Overvalued in 2026?
Based on GuruFocus' analysis, Harte-Hanks stock appears to be overvalued.
The current stock price of $4.29 is trading 3.3% above its estimated GF Value™ of $4.15.
GuruFocus considers Harte-Hanks to be Fairly Valued.
Key valuation signals for HHS:
Debt-to-EBITDA: -1.89
GF Value™: $4.15 vs. price of $4.29 (3.3% above fair value)
No single metric tells the full story. See the HHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
53GF Score
Get the complete analysis for HHS
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HHS has been successfully added to your 
